News

Insight Molecular Diagnostics Inc.: IMDX Reports Q2 2025 Results and Momentum Toward GraftAssureDx Launch
Reiterating timelines for FDA submission in 2025Transplant clinical trial has attracted leading transplant hospitalsBooked first revenue from first-generation GraftAssureIQ research-use-only kits; beg ...
A Giant Indian Drugmaker Failed to Fix Safety Breaches. The FDA Let It Off the Hook Again and Again.
Megan Rose and Debbie Cenziper ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. The dispatches from one of ...